Cancer, Bladder Unknown Status Phase 2 Trials for Sorafenib (DB00398)

Also known as: Bladder Cancers / Bladder Cancer / Malignant neoplasm of urinary bladder NOS / Bladder neoplasms malignant / Malignant neoplasm of bladder / Urinary Bladder Cancer / Malignant neoplasm of bladder, part unspecified / Bladder cancer NOS / Ca bladder

IndicationStatusPhase
DBCOND0092003 (Cancer, Bladder)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01222676Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the BladderTreatment